BURLINGTON, Mass., Oct. 15, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it will host an Investor Day on Wednesday, December 10, 2025, at the Company's biorepository facility in Indianapolis, Indiana. This event will provide invited investors and analysts with a unique opportunity to gain an in-depth understanding of Azenta's operations, innovations, and strategic initiatives.
Morning Facility Tour
The day will begin with an invite-only guided tour of Azenta's state-of-the-art biorepository facility in Indianapolis. Attendees will have the chance to explore the facility and gain firsthand insights into the Company's cutting-edge technologies and operational capabilities.
Afternoon Executive Presentations
Following lunch, John Marotta, President and Chief Executive Officer, and Lawrence Lin, Executive Vice President and Chief Financial Officer, along with other senior leaders, will present a comprehensive update on the Company's strategic direction, market opportunities, and long-term financial outlook. Additionally, there will be opportunities for question-and-answer sessions, allowing the investment community to engage directly with the management team.
Event Details (Eastern Time)
Registration:
Due to space limitations, in-person attendance for institutional investors, analysts, and select shareholders is by invitation only and advanced registration is required. Further details regarding registration will be forthcoming.
Virtual Participation
A live webcast of the afternoon presentations will be available on the Investor Relations section of Azenta's website at https://investors.azenta.com/events beginning at 1:00 PM ET and concluding at approximately 3:30 PM ET. A replay of the webcast will be available on the website the following day.
About Azenta Life Sciences
Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling life science organizations around the world to bring impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Our global team delivers and supports these products and services through our industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.
INVESTOR CONTACTS:
Yvonne Perron
Vice President, Financial Planning & Analysis, and Investor Relations
This email address is being protected from spambots. You need JavaScript enabled to view it.
Maria Isabel Cuartas
Manager, Investor Relations
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | US$30.97 |
| Daily Change: | -0.53 -1.68 |
| Daily Volume: | 533,122 |
| Market Cap: | US$1.420B |
August 05, 2025 July 31, 2025 May 13, 2025 | |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
